Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44,010Revenue $M4,934Net Margin (%)22.4Z-Score7.0
Enterprise Value $M44,392EPS $3.5Operating Margin %31.6F-Score6
P/E(ttm))36.8Cash Flow Per Share $7.1Pre-tax Margin (%)31.5Higher ROA y-yY
Price/Book7.310-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales7.65-y EBITDA Growth Rate %17.6Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow12.9y-y EBITDA Growth Rate %29.1ROA % (ttm)12.7Higher Current Ratio y-yY
Dividend Yield %0.3Insider Buy (3m)0ROE % (ttm)23.1Less Shares Outstanding y-yN
Payout Ratio %7.0Shares Outstanding M200ROI % (ttm)11.5Gross Margin Increase y-yN

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGRichard Perry 2014-09-30 Buy 6.5%$231.98 - $262.64
($248.14)
$ 220.57-11%New holding, 695800 sh.695,800
SHPGJohn Paulson 2014-09-30 Add6.09%$231.98 - $262.64
($248.14)
$ 220.57-11%Add 168.7%9,046,000
SHPGDaniel Loeb 2014-09-30 Buy 2.2%$231.98 - $262.64
($248.14)
$ 220.57-11%New holding, 750000 sh.750,000
SHPGDavid Tepper 2014-09-30 Buy 0.71%$231.98 - $262.64
($248.14)
$ 220.57-11%New holding, 185944 sh.185,944
SHPGMario Gabelli 2014-09-30 Buy 0.05%$231.98 - $262.64
($248.14)
$ 220.57-11%New holding, 37850 sh.37,850
SHPGJean-Marie Eveillard 2014-09-30 Buy 0.01%$231.98 - $262.64
($248.14)
$ 220.57-11%New holding, 15000 sh.15,000
SHPGKen Fisher 2014-09-30 Reduce$231.98 - $262.64
($248.14)
$ 220.57-11%Reduce -39.56%2,827
SHPGJohn Paulson 2014-06-30 Add0.84%$142.83 - $234.98
($172.9)
$ 220.5728%Add 33.07%3,366,539
SHPGKen Fisher 2014-06-30 Add$142.83 - $234.98
($172.9)
$ 220.5728%Add 91.13%4,677
SHPGAndreas Halvorsen 2014-06-30 Sold Out -0.25%$142.83 - $234.98
($172.9)
$ 220.5728%Sold Out0
SHPGAndreas Halvorsen 2014-03-31 Reduce-0.55%$139.18 - $171.77
($153.85)
$ 220.5743%Reduce -67.31%399,840
SHPGAndreas Halvorsen 2013-12-31 Add0.25%$113.87 - $140.87
($131.38)
$ 220.5768%Add 43.92%1,223,005
SHPGJohn Paulson 2013-12-31 Reduce-0.24%$113.87 - $140.87
($131.38)
$ 220.5768%Reduce -11.03%2,529,854
SHPGAndreas Halvorsen 2013-09-30 Add0.1%$95.78 - $123.53
($110.61)
$ 220.5799%Add 22.64%849,800
SHPGJohn Paulson 2013-06-30 Add0.98%$86.59 - $99.85
($93.74)
$ 220.57135%Add 107.43%2,843,500
SHPGAndreas Halvorsen 2013-06-30 Buy 0.37%$86.59 - $99.85
($93.74)
$ 220.57135%New holding, 692950 sh.692,950
SHPGMario Gabelli 2013-03-31 Sold Out -0.003%$89.83 - $101.63
($95.88)
$ 220.57130%Sold Out0
SHPGJohn Paulson 2012-09-30 Buy 0.99%$84.65 - $95.05
($89.88)
$ 220.57145%New holding, 1370800 sh.1,370,800
SHPGJohn Hussman 2012-09-30 Sold Out -0.3%$84.65 - $95.05
($89.88)
$ 220.57145%Sold Out0
SHPGKen Fisher 2012-09-30 Reduce-0.14%$84.65 - $95.05
($89.88)
$ 220.57145%Reduce -99.55%2,480
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SHPG Daniel Loeb 2014-09-30750,0000.382.2New Buy
SHPG David Tepper 2014-09-30185,9440.090.71New Buy
SHPG Jean-Marie Eveillard 2014-09-3015,0000.010.01New Buy
SHPG Richard Perry 2014-09-30695,8000.356.5New Buy
SHPG Mario Gabelli 2014-09-3037,8500.020.05New Buy
SHPG John Paulson 2014-09-309,046,0004.539.7+168.7%
SHPG Ken Fisher 2014-09-302,82700-39.56%
Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about SHPG :

    Quarterly/Annual Reports about SHPG:

    News about SHPG:

    Articles On GuruFocus.com
    Shire Set To Acquire NPS Pharmaceuticals for $5.2 Billion Jan 15 2015 
    Invesco European Growth Fund Comments on Shire PLC Dec 30 2014 
    Invesco European Growth Fund Q4 2014 Management’s Discussion Dec 30 2014 
    Activist Investor Dan Loeb Stays Active in Third Quarter Dec 08 2014 
    David Tepper Buys 4 New Stocks in Q3 Nov 18 2014 
    Invesco European Growth Fund Q3 2014 Commentary Oct 29 2014 
    Weekly 52-Week Highs Highlight: KSS, SHPG, LB, RSG Sep 28 2014 
    Invesco European Growth Fund Comments on Shire PLC Jul 29 2014 
    Invesco European Growth Fund Second Quarter 2014 Commentary Jul 29 2014 
    Weekly 52-Week Highs Highlight: SHPG, ILMN, UA, WDAY Feb 23 2014 


    More From Other Websites
    2:30 am Shire's investigational SHP609, idursulfase-IT, receives FDA Fast Track Designation for the... Jan 27 2015
    How Will M&A ETFs Perform In 2015? Many Deals Lined Up Jan 26 2015
    Shire's Elvanse Gets Positive Response for ADHD in Adults - Analyst Blog Jan 26 2015
    SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Jan 26 2015
    Why I Would Buy International Consolidated Airlines Grp And Shire PLC But Sell Enquest Plc Jan 26 2015
    Shire Comments on FDA Approval of Natpara�® Jan 26 2015
    Shire's Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the... Jan 26 2015
    Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA® (parathyroid... Jan 23 2015
    Sanofi's Cerdelga Cleared in the EU for Gaucher Disease - Analyst Blog Jan 23 2015
    The Zacks Analyst Blog Highlights: Alcatel-Lucent, Intercontinental Hotels Group and Shire - Press... Jan 22 2015
    Shire Added to Global 100 Sustainability Index Jan 22 2015
    Positive Response From European Decentralised Procedure for Elvanse Adult® ▼ (lisdexamfetamine... Jan 22 2015
    Positive Response from European Decentralised Procedure for Elvanse Adult®▼ (lisdexamfetamine... Jan 22 2015
    Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog Jan 21 2015
    Shire Added to Global 100 Sustainability Index Jan 21 2015
    CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog Jan 21 2015
    Beating the Greece Scare: 3 Stock Picks - Analyst Blog Jan 21 2015
    Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On... Jan 20 2015
    Why I’m Selling GlaxoSmithKline plc And Buying Shire PLC Jan 20 2015
    Roche to Acquire French Biotechnology Company Trophos - Analyst Blog Jan 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK